Joel E Michalek
Overview
Explore the profile of Joel E Michalek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
2264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brenner A, Patel T, Bao A, Phillips W, Michalek J, Youssef M, et al.
Nat Commun
. 2025 Mar;
16(1):2079.
PMID: 40055350
Rhenium (Re) Obisbemeda (RNL), chelated-Re encapsulated in nanoliposomes and delivered to brain tumors via convection enhanced delivery (CED), was evaluated in a Phase 1 dose escalation trial (NCT01906385). The primary...
2.
Das D, Wang X, Chiu Y, Bouamar H, Sharkey F, Lopera J, et al.
J Natl Cancer Inst
. 2024 Aug;
116(12):1961-1978.
PMID: 39189979
Background: The incidence and mortality rates of hepatocellular carcinoma among Hispanic individuals in the United States are much higher than in non-Hispanic White people. We conducted multi-omics analyses to elucidate...
3.
Chauhan S, Lian E, Habib I, Liu Q, Anders N, Bugg M, et al.
Sci Rep
. 2024 Aug;
14(1):18936.
PMID: 39147820
Rhabdomyosarcoma (RMS) is the most common childhood soft tissue sarcoma. For the alveolar subtype (ARMS), the presence of the PAX3::FOXO1 fusion gene and/or metastases are strong predictors of poor outcome....
4.
Clark A, Villarreal M, Huang S, Jayamohan S, Rivas P, Hussain S, et al.
Cancer Lett
. 2024 Jun;
597:217063.
PMID: 38925361
In this study we have identified POLθ-S6K-p62 as a novel druggable regulator of radiation response in prostate cancer. Despite significant advances in delivery, radiotherapy continues to negatively affect treatment outcomes...
5.
Edwards D, Kroepfl G, Jackson J, Chen S, Hudson-Price L, Srinivasa G, et al.
Transgenic Res
. 2024 Jun;
33(4):229-241.
PMID: 38851650
Rhabdomyosarcoma (RMS) is a solid tumor whose metastatic progression can be accelerated through interleukin-4 receptor alpha (Il4ra) mediated interaction with normal muscle stem cells (satellite cells). To understand the function...
6.
Das D, Wang X, Chiu Y, Bouamar H, Sharkey F, Lopera J, et al.
medRxiv
. 2024 May;
PMID: 38746245
Background: The incidence and mortality rates of hepatocellular carcinoma (HCC) among Hispanics in the United States are much higher than those of non-Hispanic whites. We conducted comprehensive multi-omics analyses to...
7.
Cheng C, Byrne J, Hernandez B, Michalek J, Kerns J, Ramsey P, et al.
Am J Obstet Gynecol MFM
. 2024 Feb;
6(4):101314.
PMID: 38373499
No abstract available.
8.
Salman U, Schwartz J, McMahan A, Michalek J, Phillips W
J Hypertens
. 2023 Dec;
42(3):572-578.
PMID: 38088427
Objective: To assess the rate of gastric emptying in spontaneously hypertensive rats (SHR) and to evaluate rapid gastric emptying as a possible predisposing factor for hypertension. Rapid gastric emptying of...
9.
Javaid A, Michalek J, Gruslova A, Hoskins S, Ahsan C, Feldman M
Catheter Cardiovasc Interv
. 2023 Nov;
103(1):30-41.
PMID: 37997292
Background: Previous studies have compared Impella use to intra-aortic balloon pump (IABP) use in patients with acute myocardial infarction and cardiogenic shock (AMI-CS) undergoing percutaneous coronary intervention (PCI). Our objective...
10.
Hung C, Chen M, DeArmond D, Chiu C, Limboy C, Tan X, et al.
Cell Rep
. 2023 Sep;
42(9):113067.
PMID: 37659081
Tumor-associated macrophages (TAMs) are integral to the development of complex tumor microenvironments (TMEs) and can execute disparate cellular programs in response to extracellular cues. However, upstream signaling processes underpinning this...